2D Bipyrimidine silver(I) nitrate: Synthesis, X-ray structure, solution chemistry and anti-microbial activit by Massoud, Alshima'a A. et al.
Chalmers Publication Library
2D Bipyrimidine silver(I) nitrate: Synthesis, X-ray structure, solution chemistry and
anti-microbial activit
This document has been downloaded from Chalmers Publication Library (CPL). It is the author´s
version of a work that was accepted for publication in:
Inorganic Chemistry Communications (ISSN: 1387-7003)
Citation for the published paper:
Massoud, A. ; Langer, V. ; Gohar, Y. (2011) "2D Bipyrimidine silver(I) nitrate: Synthesis, X-
ray structure, solution chemistry and anti-microbial activit". Inorganic Chemistry
Communications, vol. 14(4),  pp. 550-553.
http://dx.doi.org/10.1016/j.inoche.2011.01.022
Downloaded from: http://publications.lib.chalmers.se/publication/138551
Notice: Changes introduced as a result of publishing processes such as copy-editing and
formatting may not be reflected in this document. For a definitive version of this work, please refer
to the published source. Please note that access to the published version might require a
subscription.
Chalmers Publication Library (CPL) offers the possibility of retrieving research publications produced at Chalmers
University of Technology. It covers all types of publications: articles, dissertations, licentiate theses, masters theses,
conference papers, reports etc. Since 2006 it is the official tool for Chalmers official publication statistics. To ensure that
Chalmers research results are disseminated as widely as possible, an Open Access Policy has been adopted.
The CPL service is administrated and maintained by Chalmers Library.
(article starts on next page)
2D Bipyrimidine silver(I) nitrate: synthesis, X-ray structure, 
solution chemistry and anti-microbial activity 
   
Alshima'a A. Massoud*
a
, Vratislav Langer
a
, Yousry M. Gohar
b
, Morsy A. Abu-Youssef
c
, Janne 
Jänis
d
 and Lars Öhrström*
a
 
 
a Dept. of Chemical and Biological Engineering, Chalmers University of Technology, SE-412 96 Göteborg, Sweden. Fax: +46 31 
772 3858; E-mail: shimo@chalmers.se; langer@chalmers.se;  ohrstrom@chalmers.se; Tel: +46 31 772 3050; 
b Dept. of Microbiology, P.O. Box 426 Ibrahimia, 21321 Alexandria, Egypt; E-mail: ymgohar@yahoo.com  
c Chemistry Dept., Alexandria University, P.O. Box 426 Ibrahimia, 21321 Alexandria, Egypt;  E-mail: morsy5@link.net  
d Dept. of Chemistry, University of  Eastern Finland, P.O. Box 111, FI-80101, Joensuu, Finland; E-mail: janne.janis@uef.fi 
 
 
Abstract 
 
 
Synthesis and X-ray single crystal structure analysis of the compound {[Ag2(μ2-bpym)(μ-O-
NO3)2]}n, (1), (where bpym = 2,2’-bipyrimidine) are presented. Compound (1) has a (6,3)-2D 
honeycomb structure with a tetrahedral coordination geometry around the Ag(I) ion. In contrary 
to the solid state structural investigation, ESI-MS for (1) in solution shows a strong peak at m/z 
423.0269 which indicates that the [Ag(bpym)2]
+
 cation is dominating instead of [Ag2(bpym)]
2+
. 
The anti-microbial activity of (1) was screened against 15 multi-drug resistant bacteria in 
comparison to silver(I) sulphadiazine and it showed a high activity against Burkholderia mallei 
which causes glanders; with a MIC value of 4μg/ml.  
Keywords: silver(I) compounds, 2,2’-bipyrimidine, X-ray structure, anti-microbial activity.    
Polymeric silver(I) compounds have recently attracted a great interest as versatile components in 
supramolecular compounds, [1-4] for photoluminescent [5], medicinal [6] and anti-microbial 
purposes [7-12]. The latter application has a long history even predating the discovery of 
microorganisms, [13-14] and before the introduction of modern antibiotics, silver in various 
forms was used for several medical indications. Our research group has synthesized and 
structurally characterized a number of monomeric, dimeric and 1D silver(I) compounds with N-
donor heterocyclic ligands, most of which showed considerable anti-microbial activities against 
multi-drug resistant bacteria [15-22].  
Since Ag(I) has the preference to form linear, trigonal planar or tetrahedral coordination 
geometries and often serves as simple spacer or connector (L-M-L coordination synthon), the 
geometry of the formed supramolecular structure depends mainly on the choice of polydentate 
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ligand [23]. Here we have chosen 2,2’-bipyrimidine (bpym) as a bis-bidentate ligand which can 
bridge several metal centres. 
Compound (1) was synthesized
1 
in a good crystalline form suitable for single crystal X-ray 
diffraction
2
 upon direct mixing of AgNO3 in water, and the corresponding organic ligand, 
(bpym) in ethanol, in a molar ratio Ag:L = 1:2. High resolution ESI-MS for (1) was performed in 
a DMSO/CH3OH mixture to detect different cationic species in solution
3
. Antimicrobial 
activities of (1) are calculated as (MIC) values or Minimum Inhibitory Concentrations
4
.  
The structure of {[Ag2(μ2-bpym)(μ-O-NO3)2]}n is shown in Fig. 1. The bpym ligand is (μ2-
N1,N1
i
,N2,N2
i
) chelating and bridging two silver(I) ions via its four nitrogen atoms forming two 
five-membered rings Ag1/N1/C2/C2
i
/N2
i
 and N2/C2/C2
i
/N1
i
/Ag1
i
. Each silver(I) atom is further 
coordinated to two nitrate groups forming a distorted tetrahedron defined by N1/N2
i
/O33/O33
iii
. 
A CSD search [24] revealed 333 structures for bpym with different transition metals while only 
four Ag(I) structures were found: [Ag4(hfac)4(μ2-bpym)3], [25] {[Ag(μ2-bpym)]}n.nClO4, [25]
 
{[Ag2(μ2-bpym)(μ2-ox)]}n.4nH2O [25] and [Ag(μ2-bpym)][Cr(μ2-ox)2(H2O)2].2H2O  [26] (where 
hfac = 1,1,1,5,5,5-hexafluoroacetylacetonate and ox = the oxalate anion C2O4
2-
).  [Ag4(hfac)4(μ2-
bpym)3] is a tetramer with two distorted square planar and two trigonal prismatic Ag(I) atoms, 
while compounds {[Ag(μ2-bpym)]}n.nClO4 and [Ag(μ2-bpym)][Cr(μ2-ox)2(H2O)2].2H2O have 
both 1D structure consisting of [Ag(μ2-bpym)]
+
 repeating units where the bpym ligand is 
chelating and bridging two Ag(I) atoms. The compound {[Ag2(μ2-bpym)(μ2-ox)]}n.4nH2O also 
has a 1D structure where [Ag2(μ2-bpym)]
2+
 cationic units are connected by oxalate anions 
(C2O4)
2-
.  Selected bond lengths and angles for (1) are listed together with comparable structures 
in Table 1. The Ag-N bond distances (2.32 to 2.55Å) are longer than those found for L-Ag-L 
linear compounds [18-19] and are correlated to small N-Ag-N chelation angles for all these 
compounds (65 to 72°).    
Weak interactions between the Ag(I) ion and adjacent oxygen atoms are also found; Ag…O32 
and Ag…O33ii are 2.981(6) and 2.989(5)Å, respectively [Symmetry codes: (i) –x, 1-y, -z; (ii) ½-
x, -½+y, ½-z and (iii) ½-x, ½+y, ½-z]. The nitrate groups act as (μ-O) bridging Ag(I) ions 
through one oxygen atom (O33) to form 1D helices in b direction, see Fig. 2, with a weak 
interaction between the superimposed Ag(I) ions; Ag…Agv and Ag…Agvi is 3.5204(6)Å, 
[symmetry codes: (v) x, -1+y, z and (vi) x, 1+y, z]. Similar helices are found for the compound 
[Ag(2,2’-bipyridine)(NO3)]n [27] where nitrate groups are bridging the [Ag(2,2’-bipyridine)]
+
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units to form 1D chain of molecules with no Ag…Ag interactions. In case of (1) both bridging 
bpym ligands and nitrate groups extend the structure to (6,3)-2D honeycomb sheet (considering 
Ag(I) ions as nodes) in (b, c)- plane, see Fig. 3. Strong π-π stacking between the five-membered 
rings and the pyrimidine rings of same sheet is found, while no interactions between the 
pyrimidine rings themselves could be found; centroid–centroid distances are 3.520(2) and 
3.390(3) Å with β angles (offset angle) 23 and 17°, respectively.  
ESI-MS is a technique used for detection of different ionic species (cations or anions) possibly 
present in solution and/or in gas-phase and account for their relative stabilities under 
experimental conditions [28]. For compound (1), a very strong peak is observed at m/z 423.0269 
which is consistent with the calculated value for [Ag(bpym)2]
+
 (423.02 for C16H12AgN8
+
) instead 
of the expected cation [Ag2(bpym)]
2+
 found in the solid-state structure. Two minor peaks are also 
detected at m/z 264.9670 and 591.9208 which can be assigned to [Ag(bpym)]
+
 and 
[Ag2(bpym)2(NO3)]
+
 cations; calculated values are 264.96 and 591.92 for C8H6AgN4
+
 and 
C16H12Ag2N9O3
+
, respectively. Also, the observation of a characteristic 
107
Ag/
109
Ag isotopic 
peak doublet (~52 : 48) further identified the 1:2 compound [29].  
The compound in solution thus prefers the stoichiometry 1:2 (Ag:L) with a suggested tetrahedral 
coordination geometry around the Ag(I) ion  as found in the previously mentioned compounds 
{[Ag(μ2-bpym)]}n.nClO4 and {[Ag2(μ2-bpym)(μ2-ox)]}n.4nH2O [25].  The nitrate coordination to 
the Ag(I) centres in (1) is stabilizing the sheets formed in the solid-state with the stoichiometry 
2:1 (Ag:L) while in solution the nitrates have been solvated giving the ligand more chance to 
directly attack the half naked [Ag(bpym)]
+
 and form the 1:2 (Ag:L) cation [Ag(bpym)2]
+
.  
In some related studies the ESI-MS of the silver(I) trifluoromethan sulfonate (AgO3SCF3) 
compound with 3,6-di(2-pyridyl)pyridazine in CH3CN were consistent with X-ray 
crystallography where the same cations [Ag(L)2]
+
 (Ag:L = 1:2) were found [30]. Similarly, the 
ESI-MS for the compound [Ag(4,5-diazafluoren-9-one)2]NO3 [21] showed only one strong peak 
representing the complex [Ag(L)2]
+
 with (Ag:L = 1:2). On the contrary, the ESI-MS for a 
solution containing AgBF4 and excess bidentate 1,12-diazaperylene ligand indicate the formation 
of the 1:1 (90%) Ag:L complex while the expected 1:2 complex is only observed as a minor peak 
(10%) [31]. Thus the complexation behaviour of silver(I) ions in solution is complicated. 
Compound (1) shows activities comparable with the commercially used silver(I) sulphadiazine 
against most Gram-positive bacteria used in this test, MIC values are listed in Table 2. The 
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highest activity recorded  for (1) was against the Gram-negative Burkholderia mallei which 
causes glanders [32]; MIC value 4μg/ml.   
In conclusion, we have synthesized and structurally characterized the compound {[Ag2(μ2-
bpym)(μ-O-NO3)2]}n. The compound shows a broad spectrum antibacterial activity against all 
the test organisms with stronger effect against the Gram-negative Burkholderia mallei than 
silver(I) sulphadiazine under the same test conditions. This activity should be interpreted on the 
bases of solution chemistry of the compound, where [Ag(bpym)2]
+
 cation is detected by ESI-MS.   
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Notes and References  
 
1 To an aqueous solution (20 cm3) of AgNO3 (0.34g, 2.0 mmol), an ethanolic solution of 4 mmol of 2,2’-bipyrimidine (0.60g) was 
added with continuous stirring . The mixture was then heated till boiling, followed by filtration. The clear filtrate was allowed to 
stand at room temperature for a couple of weeks. Colorless needles of (1) suitable for X-ray measurements were collected and 
dried in air, with a yield ~ 85% with respect to AgNO3. IR was recorded on a Bruker IFS-125 model FT-IR spectrophotometer as 
KBr pellets; (v, very; s, strong; m, medium; w, weak; br, broad; sh, shoulder): 3090 s, 1609 w, 1560 vs, 1449 vs, 1408 sh, 1457 
vs, br, 1283 vs, 1264 vs, 1142 m, 1104 m, 1015 s, 827 s, 807 m, 758 s, 685 w, 661 s, 593 m, 409 m, 388 m, 343 w, 317 w, 272 w. 
Elemental analyses (C, H, N) were carried out by Mikroanalytisches Laboratorium KOLBE, Mülheim an der Ruhr, Germany. 
Calculated values are: C, 19.22; H, 1.61 and N, 16.81%. Found values are: C, 19.17; H, 1.42 and 16.53%. 
2 Crystallographic measurements were made on a Siemens Smart CCD diffractometer with graphite-monochromated Mo Kα 
radiation (λ = 0.71073Å) at 153 K. The structure was solved by direct method and subsequent full-matrix least-squares 
refinement, including anisotropic thermal parameters for all non-hydrogen atoms. Hydrogen atoms were refined isotropically 
with use of geometrical constrains. The calculations were carried out using SHELXTL program package. Empirical formula: 
C16H12Ag4N12O12, F.W. 995.86, Crystal system: monoclinic, Space group: C2/c, a=20.940(2), b=3.5204(4), c=19.477(2)Å, 
β=122.017(2)°,  V =1217.4(2)Å3, Z=2, D(calc)=2.177 Mg/m
3, μ=3.262mm-1, F(000) = 952, Crystal size: 0.40x 0.08x 0.06 mm3, θ 
range: 2.31 to 25.05°, Index ranges: -24<=h<=24, -4<=k<=4, -23<=l<=23, Reflections collected: 3998, Independent reflections: 
1070 [R(int) = 0.0440], Completeness to θ=25.05°: 99.1%, Absorption correction: multi-scan, T(Max)=0.8283, T(min)=0.3553, 
Refinement method: full-matrix least-squares on F2, Data/ restraints/ parameters: 1070/ 0/ 100, Goodness-of-fit: 1.006, Final R 
indices [I>2σ(I)]: R1 = 0.0537 and wR2 = 0.1604, R indices (all data): R1 = 0.0547 and wR2 = 0.1623, largest diff. peak and 
hole: 1.935 and -2.232 e.Å-3.   
3 High-resolution ESI-MS analysis was performed on a Bruker APEX-Qe hybrid quadrupole Fourier transform ion cyclotron 
resonance (Q–FT-ICR) mass spectrometer, equipped with an Apollo-II ESI source and a 4.7-T superconducting magnet. We used 
as gentle conditions as possible to ascertain that the MS data would represent solution characteristics rather than dissociation 
products in the gas-phase.  CapExit: 300 V, Skimmer1: 12 V, Ion-funnel1: 150 V, Skimmer2: 10 V, Ion-funnel2: 15 V, Drying 
gas: 180 °C, Drying gas: 5.0 bar and Nebul. Gas: 1.0 bar. The instrument was operated in positive ion mode only. Compound (1) 
was dissolved in DMSO and diluted with MeOH. This solution was infused into the ESI source at a flow rate of 1.5 μl/min and 
positive ions were detected. The instrument was operated with Bruker XMASS 7.0.8 software and spectra were processed/ 
analyzed with the use of Bruker Data Analysis 3.5 software. 
 
4 Antimicrobial activity of (1) was determined according to the recommendations of NCCLS (1999), National Committee for 
Clinical Laboratory Standard, by the use of broth microdilution method. Minimum inhibitory concentrations (MICs) for the 
tested compound were conducted using 15 different bacterial clinical isolates (Department of Vascular Surgery, Faculty of 
Medicine, Alexandria University, Egypt) and are all resistant strains for commonly used antibiotics. The test material was 
dissolved in DMSO to give a stock solution that subsequently diluted in the growth medium to give final concentrations of 256, 
128, 64, 32, 16, 8, 2, 1, and 0.5 µg of compound/ml. A final concentration of 5% DMSO was present in all assays. Bacteria were 
cultured in Mueller Hinton broth (MHB) for 24 h at 35 °C. A toxicity bioassay against Daphnia was conducted using standard 
methods. 
5 Table 2 footnote: The MIC values are corresponding to the lowest concentrations (μg/ml) that inhibited the bacterial growth. 
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